CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy

NCT06135909 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-01-18

No results posted yet for this study

Summary

CHina Registry for the chAracteristics and Management strategieS of patiEnts With Pulmonary Hypertension Using Targeted Therapy (CHASE Study)

Conditions

  • Pulmonary Hypertension

Sponsors & Collaborators

  • Chinese Pulmonary Vascular Disease Research Group

    lead OTHER

Principal Investigators

  • Zhihong Liu, M.D., Ph.D · Chinese Academy of Medical Sciences, Fuwai Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06135909 on ClinicalTrials.gov